The Cooper Companies, Inc. (COO) Key Statistics & Metrics

The Cooper Companies, Inc. (COO) has an ST Score of 43.6 out of 100, an overall grade of C. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Wall Street's consensus rating on COO is Buy based on 28 analyst ratings. Our own ST Score grades it C (43.6/100). This is data, not investment advice — always do your own research.

The Cooper Companies, Inc. (COO) earns a valuation grade of C-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

The Cooper Companies, Inc. (COO) earns a growth grade of B-, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

The Cooper Companies, Inc. (COO) earns a profitability grade of A, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

The Cooper Companies, Inc. (COO) earns a financial strength grade of C, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for The Cooper Companies, Inc. (COO) is $65.75 from 28 analysts, which is +0.2% versus the recent price of $54.12.

The Cooper Companies, Inc. (COO) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.